Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1623 1691 1693
This examiner grants 44% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18256401 | REDUCTION OF RANCIDITY OF VEGETABLE OILS | Final Rejection | DSM IP Assets B.V. |
| 17624379 | AMINE-FUNCTIONALIZED SACCHARIDE POLYMERS PREPARED BY HYPOCHLORITE OXIDATION | Non-Final OA | INTEGRITY BIO-CHEMICALS, LLC |
| 19421869 | COMPOSITIONS OF HYDROXYPROPYL-BETA-CYCLODEXTRIN AND METHODS OF PURIFYING THE SAME | Non-Final OA | Beren Therapeutics P.B.C. |
| 17435683 | COMPOUNDS FOR PREVENTION AND TREATMENT OF POST-OPERATIVE COGNITIVE DYSFUNCTION | Final Rejection | ABREXA PHARMACEUTICALS, INC. |
| 19336466 | GALNAC MONOMER COMPRISING RIBOSE RING OR DERIVATIVE STRUCTURE THEREOF AND USE THEREOF IN LIVER-TARGETED DELIVERY OF SMALL NUCLEIC ACID DRUGS | Final Rejection | Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. |
| 18665849 | PHARMACEUTICAL COMPOSITION FOR TREATING COLORECTAL CANCER, INCLUDING TUMOR-TARGETED LIPOSOMES CONTAINING PLATYCODIN D2 | Non-Final OA | RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY |
| 18192291 | NUCLEOSIDES AND NUCLEOTIDES WITH 3' VINYL BLOCKING GROUP | Final Rejection | Illumina, Inc. |
| 18717426 | USE OF SODIUM FORMATE IN PREPARATION OF AN ANTI-INFECTIVE DRUG | Non-Final OA | SUN YAT-SEN UNIVERSITY |
| 17779706 | SYNTHESIS OF 3 -RNA OLIGONUCLEOTIDES | Final Rejection | ALNYLAM PHARMACEUTICALS, INC. |
| 18448579 | OLIGONUCLEOTIDE PRODUCTION METHOD | Non-Final OA | AJINOMOTO CO., INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy